Position in QNCX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$50,575,083
-$746,960,757 QoQ
Shares Held
2,503,717
+110.3% QoQ
Ownership
15.4%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2
of 46 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Derivatives in QNCX
reported options exposure · as of Dec 31, 2021CallValue
$227,160,000
CallShares
90,000
PutValue
$252,400,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. QNCX ranks #17 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in QNCX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,575,083 | 2,503,717 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $797,535,840 | 1,190,352 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $452,088,976 | 1,386,776 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $36,525,060 | 110,682 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $5,485,050 | 36,567 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,379,948 | 53,679 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,483,870 | 59,447 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,423,872 | 59,928 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,483,507 | 61,407 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $77,380,056 | 248,013 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $75,905,047 | 595,801 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $121,825,606 | 457,991 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $153,361,596 | 345,409 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $81,918,460 | 66,170 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $227,160,000 | 90,000 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $1,430,302,844 | 566,681 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $252,400,000 | 100,000 | Put | Sole | 2022-02-14 | |
| 2021-09-30 | $109,992,000 | 6,000 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $83,832,236 | 4,573 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $458,300,000 | 25,000 | Put | Sole | 2021-11-15 | |
| 2021-03-31 | $47,883,870 | 6,645 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $578,324,040 | 104,090 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $233,176,060 | 25,181 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $234,353,302 | 25,691 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||